Mechanismen der Immunomodulation nach Transfusion allogener und autologer Erythrozytenkonzentrate

Literatur

• 1 Goodnough L T, Brecher M E, Kanter M H, AuBuchon J P. Transfusion medicine: Blood transfusion.  N Engl J Med. 1999;  340 438-447
• 2 Blumberg N, Heal J M. Immunomodulation by blood transfusion: an envolving scientific and clinical challenge.  Am J Med. 1996;  101 299-308
• 3 Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD.  Vox Sang. 1998;  74 189-200
• 4 Blumberg N, Heal J M. The transfusion immunomudulation theory: The Th1/ Th2 paradigm as an analogy with pregnancy as a unifying mechanism.  Sem Hematol. 1996;  33 329-340
• 5 Vamvakas E C, Blajchman M A. Universal WBC reduction: the case for and against.  Transfusion. 2001;  41 691-712
• 6 Innerhofer P, Luz G, Spötl L. et al . Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T-cells.  Transfusion. 1999;  39 1089-1096
• 7 Innerhofer P, Tilz G, Fuchs D. et al . Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis.  Transfusion. 2000;  40 821-827
• 8 Weiss G, Fuchs D, Hausen A. et al . Iron modulates Interferon-gamma effects in the human myelomonocytic cell line THP-1.  Exp Hematol. 1992;  20 505-510
• 9 Kalechman Y, Herman S, Gafter U, Sredni B. Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and Il-2R expression.  Cell Immunol. 1993;  148 114-129
• 10 Heiss M M, Mempel W, Jauch K W. et al . Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery.  Lancet. 1993;  342 1328-1333

Korrespondenzadresse